HIST is pleased to announce a new collaboration with Hedera Dx, a Swiss company focused on next generation sequencing (NGS) oncology solutions.

Through this partnership, HIST will support the introduction of Hedera Dx solutions across institutions in the Middle East and North Africa (MENA), working closely with local teams on implementation, adoption and long term programs.

About Hedera Dx

Hedera Dx develops NGS oncology solutions that combine targeted panels with a dedicated software platform. The overall offering is designed to help institutions set up and run structured workflows, with a strong focus on robustness, usability and quality monitoring.

The Hedera Dx solution in brief

• ctDNA and FFPE solutions based on NGS workflows, covering a broad range of relevant genomic alterations such as SNVs, Indels, CNVs, gene fusions and MSI.

• A software platform that structures data, supports quality review and generates standardized reports for internal use.

  
  

• An implementation framework that includes onboarding, documentation and ongoing technical support.

What the collaboration covers

• Work with selected institutions in MENA that are interested in NGS solutions in oncology.

• Support deployment projects and local evaluations, in line with institutional policies and local requirements.

  
  

• Provide training and support for teams involved in NGS, data analysis and reporting activities.

The shared ambition is to make it easier for institutions in the region to access and operate advanced NGS solutions in oncology as part of their own programs and initiatives.

About HIST

HIST partners with innovative life science companies such as diagnostics and biotechs to accelerate market entry and scale across MENA through compliance & distribution. HIST brings regional expertise in compliance, market access, training and distribution, working with institutions to help them run and expand their own programs.

Important information
Hedera Dx solutions in MENA are provided for Research Use Only. They are not intended for use in diagnostic procedures or for directing individual management decisions. Availability and status may vary by country and by institution.